Artificial intelligence in population breast cancer screening: A two-year cost-effectiveness analysis.
OBJECTIVES: To investigate the cost-effectiveness of integrating artificial intelligence (AI) into breast cancer screening in Australia. Scenario analyses showed AI-supported screening was more effective, though more costly, than standard practice (ICER $1123 per additional cancer detected) and may be cost-effective.
OBJECTIVES: To investigate the cost-effectiveness of integrating artificial intelligence (AI) into breast cancer screening in Australia. Scenario analyses showed AI-supported screening was more effective, though more costly, than standard practice (ICER $1123 per additional cancer detected) and may be cost-effective.
What the study was
- Study design
- Randomized controlled trial
- Category
- Early Detection
- Maturity
- Potentially Practice-Changing
- Journal
- Social science & medicine (1982)
Why it surfaced
Relevant Early cancer detection study (early cancer detection relevance) meets standard-priority threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.